Furthermore, we validated ZNRF3/RNF43-EGFR signaling in prostate cancer, one of the several other tumors in patients besides colorectal cancer that showed a negative correlation ZNRF3/RNF43 mRNA and EGFR protein levels (Fig. 1F). This evidence concerns the gene EGFR and prostate carcinoma.